Posterior Reversible Encephalopathy Syndrome in Peritoneal Dialysis Patients: A Four-Case Series
Open Access
- 5 March 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 2003
Abstract
Background/Objectives: Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by acute neurological symptoms and vasogenic edema, usually affecting the posterior circulation. It is described in end-stage renal disease (ESRD), but its presentation in peritoneal dialysis (PD) is not well defined. We aimed to describe the clinical, radiological, and dialysis-related features of PRES in PD patients and highlight factors relevant for diagnosis and management. Materials and Methods: We conducted a retrospective descriptive case series of four ESRD patients on PD or recently transitioned from PD to hemodialysis (HD) who developed PRES at a single center. Clinical data, laboratory results, dialysis characteristics, and neuroimaging findings were obtained from medical records. PRES was diagnosed based on acute neurological symptoms in the setting of severe hypertension and uremia, with CT and/or MRI findings supportive of PRES when present and exclusion of alternative diagnoses. Results: All patients presented with acute neurological manifestations, including headache, visual disturbances, seizures, and/or altered consciousness, in the context of marked hypertension and uremia. Neuroimaging findings ranged from normal CT/MRI to subtle bilateral occipital hypodensities and, in one case, extensive supra- and infratentorial vasogenic edema with internal hydrocephalus and subependymal edema. In three patients, inadequate volume or solute control on PD prompted temporary or permanent transition to HD to improve blood pressure and fluid management. With antihypertensive therapy, seizure control when required, correction of metabolic disturbances, and optimization of dialysis, all patients recovered clinically, with time to PRES resolution ranging from 7 to 43 days. Conclusions: PRES should be considered in PD patients with new-onset seizures, visual symptoms, or unexplained changes in mental status, particularly during hypertensive crises and uremia. Early CT/MRI, prompt blood pressure control, and careful adjustment of dialysis modality appear important for achieving favorable neurological outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Dialysis for Chronic Kidney FailureJAMA, 2024
- Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosisNefrología (English Edition), 2022
- Hypogonadotropic hypogonadism due to compound heterozygous mutations TACR3 in siblingsClinical Case Reports, 2020
- A case of posterior reversible encephalopathy syndrome in a patient undergoing automated peritoneal dialysisCEN Case Reports, 2019
- Peritoneal dialysis: A factor of risk or protection for posterior reversible encephalopathy syndrome? Review of the literatureNefrología (English Edition), 2018
- Posterior reversible encephalopathy syndromeJournal of Neurology, 2017
- Posterior reversible encephalopathy syndrome—Insight into pathogenesis, clinical variants and treatment approachesAutoimmunity Reviews, 2015
- Avoiding Harm in Peritoneal Dialysis PatientsAdvances in Chronic Kidney Disease, 2012
- A case of reversible posterior leukoencephalopathy syndrome in a patient on peritoneal dialysisClinical and Experimental Nephrology, 2010
- A Reversible Posterior Leukoencephalopathy SyndromeNew England Journal of Medicine, 1996